PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPulmonary tuberculosis
MeSH D014397 - pulmonary tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008171:Lung diseases
$
Success rate
D014376:Tuberculosis
D012141:Respiratory tract infections
D014397: 
Pulmonary tuberculosis
D012830:Silicotuberculosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganLevofloxacin Levofloxacin  2011-02-10   
Ofloxacin Ocuflox  1993-07-30   
Altaire PharmaceuticalsOfloxacin Ofloxacin  2013-04-29   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%
8/8
Phase 2
42%
21/50
Phase 3
66%
21/32
Approved: 11Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
AbbVie
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use